Identification of common functional configurations among molecules

Journal of Chemical Information and Computer Sciences

Volumn 36, Issue 3, 1996, Pages 563-571

  Barnum, Doug ^a,b   Greene, Jonathan ^a,b   Smellie, Andrew ^a,b   Sprague, Peter ^a  

^a ACCELRYS INC   (United States)

^b Formerly CombiChem Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

ALGORITHM; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1;

ALGORITHMS; HIV PROTEASE INHIBITORS; HIV-1; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PLATELET ACTIVATING FACTOR; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0030137662     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci950273r     Document Type: Article

References (40)

1. Cramer, R.; Patterson, D.; Bunce, R. Comparative molecular field analysis (Comfa). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
2. Norinder, U. The alignment problem in 3d-QSAR: a combined approach using catalyst and 3D QSAR technique. European Symposium on Quantitative Structure-Activity Relationships; Barcelona, Spain, 1994.
3. Hahn, M.; Rogers, D. Receptor Surface Models. 2. Application to Quantitative Structure-Activity Relationship Studies. J. Med. Chem. 1995, 38, 2091-2102.
4. Jain, A.; Dietterich, T.; Lathrop, R.; Chapman, D.; Critchlow, R.; Bauer, B.; Webster, T.; Lozano-Perez, T. Compass: a shape based machine learning tool for drug design. J. Comp.-aided Mol. Design 1994, 8, 635-652.
5. Catalyst/Hypo Tutorial, version 2.0; BioCAD Corp.; Moutain View, CA, 1993.
6. Mayer, D.; Naylor, C. B.; Motoc, I.; Marshall, G. R. A unique geometry of the active site of angiotensin-converting-enzyme consistent with structure-activity studies. J. Comp.-aided Mol. Design 1987, 1, 3-16.
7. Dammkoehler, R.; Karasek, S.; Shands, E.; Marshall, G. Constrained Search of Conformational Hyperspace. J. Comp.-aided Mol. Design 1989, 3, 3-21.
8. Sheridan, R. P.; Nilakantan, R.; Discon, J. S.; Venkataraghavan, R. The ensemble approach to distance geometry: Application to the nicotinic pharmacophore. J. Med. Chem. 1986, 29, 899-906.
9. Brim, A.; Willet, P. Algorithms for the identification of three-dimensional maximal common substructures. J. Chem. Inf. Comput. Sci. 1987, 27, 152-158.
10. Smellie, A.; Crippen, G.; Richards, W. G. Fast Drug Receptor Mapping by Site-Directed Distances: A novel method of predicting new pharmacological leads. J. Chem. Inf. Comput. Sci. 1991, 31(3), 386-394.
11. Martin, Y.; Bures, M.; Danaher, E.; DeLazzer, J. New strategies that improve the efficiency of the 3D design of bioactive molecules. Trends in QSAR and Molecular Modelling; Wermuth, C., Ed.; ESCOM: Leiden, 1993; pp 20-26.
12. Golender, V.; Vorpagel, E. Computer-Assisted Pharmacophore Identification. 3D QSAR in Drug Design; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 137-149.
13. Smellie, A.; Teig, S. L.; Towbin, P. Poling: Promoting Conformational Variation. J. Comput. Chem. 1994, 16, 171-187.
14. Barakat, M. T.; Dean, P. M. Molecular structure matching by simulated annealing. III. The incorporation of null correspondences into the matching problem. J. Comp.-aided Mol. Design 1991, 5, 107-117.
15. Greene, J.; Kahn, S.; Savoj, H.; Sprague, P.; Teig, S. Chemical Function Queries For 3D Database Search. J. Chem. Inf. Comput. Sci. 1994, 34, 1297-1308.
16. Klopman, G. Artificial Intelligence Approach to Structure-Activity Studies. Computer Automated Structure Evaluation of Biological Activity of Organic Molecules. J. Am. Chem. Soc. 1984, 106, 7315-7321.
17. Golender, V.; Rozenblit, A. Logical and Combinatorial Algorithms for Drug Design; Research Studies Press: Wiley, Letchworth, 1983.
18. Bures, M.; Danaher, E.; DeLazzer, J.; Martin, Y. New Molecular modeling tools using three-dimensional chemical structures. J. Chem. Inf. Comput. Sci. 1994, 34, 218-223. See, also: J. Med. Chem. 1994, 37, 2011.
19. Bures, M.; Danaher, E.; DeLazzer, J.; Martin, Y. New Molecular modeling tools using three-dimensional chemical structures. J. Chem. Inf. Comput. Sci. 1994, 34, 218-223. See, also: J. Med. Chem. 1994, 37, 2011.
20. Entry IRVO in the Protein Data Bank, described in the following references: (a) Gussio, R.; Pattabiraman, N.; Zaharevitz, D.; Kellogg, G. E.; Rice, B.; Schaeffer, C. A.; Burt, S. K.; Erickson, J. W. Using Nevirapine Analogs as Structural Probes to Model Their Binding Site on HIV-1 Reverse Transcriptase. To be published. (b) Pattabiraman, N.; Gussio, R.; Topol, I.; Burt, S. K.; Erickson, J. W. An Electronic Characterization of a Congeneric Series of Nevirapine Analogs. Abstr. Pap. Am. Chem. Soc. 1994, 208. Abstract number: MEDI 33. (c) Gussio, R.; Pattabiraman, N.; Kellogg, G. E.; Bhat, T. N.; Collins, J.; Burt, S. K.; Erickson, J. W. HIV-1 Reverse Transcriptase Nevirapine Binding Site Model: A 3D Structural QSAR for Ligand Design. Abstr. Pap. Am. Chem. Soc. 1994, 208, Abstract number: MEDI 34. (d) Smerdon, S. J.; Jager, J.; Wang, J.; Kohlstaedt, L. A.; Chirino, A. J.; Friedman, J. M.; Rice, P. A.; Steitz, T. A. Structure of the Binding Site for Nonnucleoside Inhibitors of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1. Proc. Natl. Acad. Sci. 1994, 91, 3911-3915.
21. Entry IRVO in the Protein Data Bank, described in the following references: (a) Gussio, R.; Pattabiraman, N.; Zaharevitz, D.; Kellogg, G. E.; Rice, B.; Schaeffer, C. A.; Burt, S. K.; Erickson, J. W. Using Nevirapine Analogs as Structural Probes to Model Their Binding Site on HIV-1 Reverse Transcriptase. To be published. (b) Pattabiraman, N.; Gussio, R.; Topol, I.; Burt, S. K.; Erickson, J. W. An Electronic Characterization of a Congeneric Series of Nevirapine Analogs. Abstr. Pap. Am. Chem. Soc. 1994, 208. Abstract number: MEDI 33. (c) Gussio, R.; Pattabiraman, N.; Kellogg, G. E.; Bhat, T. N.; Collins, J.; Burt, S. K.; Erickson, J. W. HIV-1 Reverse Transcriptase Nevirapine Binding Site Model: A 3D Structural QSAR for Ligand Design. Abstr. Pap. Am. Chem. Soc. 1994, 208, Abstract number: MEDI 34. (d) Smerdon, S. J.; Jager, J.; Wang, J.; Kohlstaedt, L. A.; Chirino, A. J.; Friedman, J. M.; Rice, P. A.; Steitz, T. A. Structure of the Binding Site for Nonnucleoside Inhibitors of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1. Proc. Natl. Acad. Sci. 1994, 91, 3911-3915.
22. Entry IRVO in the Protein Data Bank, described in the following references: (a) Gussio, R.; Pattabiraman, N.; Zaharevitz, D.; Kellogg, G. E.; Rice, B.; Schaeffer, C. A.; Burt, S. K.; Erickson, J. W. Using Nevirapine Analogs as Structural Probes to Model Their Binding Site on HIV-1 Reverse Transcriptase. To be published. (b) Pattabiraman, N.; Gussio, R.; Topol, I.; Burt, S. K.; Erickson, J. W. An Electronic Characterization of a Congeneric Series of Nevirapine Analogs. Abstr. Pap. Am. Chem. Soc. 1994, 208. Abstract number: MEDI 33. (c) Gussio, R.; Pattabiraman, N.; Kellogg, G. E.; Bhat, T. N.; Collins, J.; Burt, S. K.; Erickson, J. W. HIV-1 Reverse Transcriptase Nevirapine Binding Site Model: A 3D Structural QSAR for Ligand Design. Abstr. Pap. Am. Chem. Soc. 1994, 208, Abstract number: MEDI 34. (d) Smerdon, S. J.; Jager, J.; Wang, J.; Kohlstaedt, L. A.; Chirino, A. J.; Friedman, J. M.; Rice, P. A.; Steitz, T. A. Structure of the Binding Site for Nonnucleoside Inhibitors of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1. Proc. Natl. Acad. Sci. 1994, 91, 3911-3915.
23. Entry IRVO in the Protein Data Bank, described in the following references: (a) Gussio, R.; Pattabiraman, N.; Zaharevitz, D.; Kellogg, G. E.; Rice, B.; Schaeffer, C. A.; Burt, S. K.; Erickson, J. W. Using Nevirapine Analogs as Structural Probes to Model Their Binding Site on HIV-1 Reverse Transcriptase. To be published. (b) Pattabiraman, N.; Gussio, R.; Topol, I.; Burt, S. K.; Erickson, J. W. An Electronic Characterization of a Congeneric Series of Nevirapine Analogs. Abstr. Pap. Am. Chem. Soc. 1994, 208. Abstract number: MEDI 33. (c) Gussio, R.; Pattabiraman, N.; Kellogg, G. E.; Bhat, T. N.; Collins, J.; Burt, S. K.; Erickson, J. W. HIV-1 Reverse Transcriptase Nevirapine Binding Site Model: A 3D Structural QSAR for Ligand Design. Abstr. Pap. Am. Chem. Soc. 1994, 208, Abstract number: MEDI 34. (d) Smerdon, S. J.; Jager, J.; Wang, J.; Kohlstaedt, L. A.; Chirino, A. J.; Friedman, J. M.; Rice, P. A.; Steitz, T. A. Structure of the Binding Site for Nonnucleoside Inhibitors of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1. Proc. Natl. Acad. Sci. 1994, 91, 3911-3915.
24. HipHop Tutorial, Version 2.3; Molecular Simulations Inc.: Sunnyvale, CA, 1995.
25. Crippen, G. M.; Havel, T. F. Distance Geometry and Molecular Conformations; Research Studies Press: Wiley Pub: 1988.
26. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaninathan, S.; Karplus, M. CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. J. Comput. Chem. 1983, 4, 2, 187-217.
27. Fletcher, R. Practical Methods of Optimization 1: Unconstrained Optimization; Wiley Pub.: 1980.
28. Ferro, D.; Hermans, J. A different best rigid-body molecular fit routine. Acta Crystallogr. 1977, A33, 345-347.
29. Yao, F. F. Computational Geometry. Handbook of Theoretical Computer Science. Volume A. Algorithms and Complexity; van Leeuwen, J., Ed.; The MIT Press/Elsevier: 1990; pp 368-374.
30. Barron, A.; Cover, T. Minimum Complexity Density Estimation. IEEE Trans. Inform. Theory 1991, 37(4), 1034-1054.
31. Harris, T. A Lower Bound for the Critical Probability in a Certain Percolation Process. Proc. Cambridge Phil. Soc. 1960, 56, 13-20.
32. Catalyst Tutorial, version 2.3; Molecular Simulations Inc.: Sunnyvale, CA, 1995.
33. Wyatt, P. G. et al. Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of HIV Type 1 Reverse Transcriptase. J. Med. Chem. 1995, 38, 1657-1665.
34. Hanasaki, Y. et al. Thiadiazole Derivatives: Highly Potent and Specific HIV-1 Reverse Transcriptase Inhibitors. J. Med. Chem. 1995, 38, 2038-2040.
35. Merluzzi, V. J.; Hargrave, K. D.; Labadia, M.; Gronzinger, K.; Skoog, M.; Wu, J. C.; Shih, C.-K.; Eckner, R. J.; Hattox, S.; Adams, J.; Rosenthal, A. S.; Faanes, R.; Eckner, R. J.; Koup, R. A.; Sullivan, J. L. Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor. Science 1990, 2150, 1411-1413.
36. Hargrave, K. D.; Proudfoot, J. R.; Grozinger, K. G.; Cullen, E.; Kapadia, S. R.; Patel, U. R.; Fuchs, V. U.; Mauldin, S. C.; Vitous, J.; Behnke, M. L.; Klunder, J. M.; Kollol, P.; Skiles, J. W.; McNeil, D. W.; Rose, J. M.; Chow, G. C.; Skoog, M. T.; Wu, J. C.; Schmidt, G.; Engel, W. W.; Eberlein, W. G.; Saboe, T. D.; Campbell, S. J.; Rosenthal, A. S.; and Adams, J. Novel Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. 1. Tricyclic Pyridobenzo- and Dipyridodiazepinones. J. Med. Chem. 1991, 34, 2231-2241.
37. Breslin, H. J.; Kukla, M. J.; Ludovici, D. W.; Mohrbacher, R.; Ho, W.; Miranda, M.; Rodgers, J. D.; Hitchens, T. K.; Leo, G.; Gauthier, D. A.; Ho, C. Y.; Scott, M. K.; De Clercq, E.; Pauwels, R.; Andries, K.; Janssen, M. A. C.; Janssen, P. A. J. Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo-[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) Derivatives. 3. J. Med. Chem. 1995, 38, 771-793.
38. Romero, D. L.; Morge, R. A.; Biles, C.; Berrios-Pena, N.; May, P. D.; Palmer, J. R.; Johnson, P. D.; Smith, H. W.; Busso, M.; Tan, C.-K.; Voorman, R. L.; Reusser, F.; Althouse, I. W.; Downey, K. M.; So, A. G.; Resnick, L.; Tarpley, W. G.; Aristoff, P. A. Discovery, Synthesis, and Bioactivity of Bis(hetroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. J. Med. Chem. 1994, 37, 999-1014.
39. Miyasaka, T.; Hiromichi, T.; Baba, M.; Hayakawa, H.; Walker, R. T.; Balzarini, J.; De Clercq, E. A Novel Lead for Specific Anti-HIV-1 Agents: 1-[(2-Hydroxyetnoxy)methyl]-6-(phenylthio)thymidine. J. Med. Chem. 1989, 32, 2507-2509.
40. Saari, W. S.; Hoffman, J. M.; Wai, J. S.; Fisher, T. E.; Rooney, C. S.; Smith, A. M.; Thomas, C. M.; Goldman, M. E.; O'Brien, J. A.; Nunberg, J. H.; Quintero, J. C.; Schleif, W. A.; Emini, E. A.; Stern, A. M.; Anderson, P. S. A New Class of Nonnucleoside, HIV-1-Specific Reverse Transcriptase Inhibitors. J. Med. Chem. 1991, 34, 2922-2925.